Treatment of Parkinson's with L-DOPA. The early discovery phase, and a comment on current problems.
Carlsson
A
A
Department of Pharmacology, University of Gothenburg, Gothenburg, Sweden. arvid.carlsson@pharm.gu.se
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D015259:Dopamine Agents / Q000627:therapeutic use*; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D009462:Neurology / Q000639:trends*; D010300:Parkinson Disease / Q000188:drug therapy*; D012106:Research
D000978:Antiparkinson Agents; D015259:Dopamine Agents; D007980:Levodopa